NCT02043067View on ClinicalTrials.gov

Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

May 31, 2013

Conditions
Tuberculosis
Interventions
OTHER

Comprehensive TB screening

All enrollees will receive a comprehensive TB screening regardless of symptom presentation.

Trial Locations (1)

Unknown

Kalingalinga HIV Care and Treatment Clinic, Lusaka

All Listed Sponsors
collaborator

Centre for Infectious Disease Research in Zambia

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

University of North Carolina, Chapel Hill

OTHER

NCT02043067 - Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV | Biotech Hunter | Biotech Hunter